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A  32-year-old  male  was  evaluated  in  the  emergency
epartment  for  worsening  asthenia,  dizziness,  headache  and
hotophobia  for  the  past  ﬁve  days.  Physical  examination
evealed  purple  and  brown  lesions  in  the  inner  thigh  and
enis,  suggestive  of  cutaneous  Kaposi’s  sarcoma  (KS).  His
ast  medical  history  was  remarkable  for  acquired  immuno-
eﬁciency  syndrome  (AIDS)  diagnosed  ﬁve  years  before  with
rratic  follow-up  in  outpatient  clinic.  He  was  hospitalized∗ Corresponding author.
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is  complicated  with  meningitis,  disseminated  tuberculosis
ith  intestinal  and  pulmonary  involvement,  cytomegalovirus
isseminated  infection  and  neurosyphilis.  After  discharge,
e  started  highly  active  antiretroviral  therapy  (HAART),
owever  the  patient  referred  that  he  was  complying  with
nti-tuberculostatic  drugs  but  he  was  not  taking  HAART  nor
rophylactic  antibiotics/antifungals.
He  was  admitted  for  recurrent  cryptococcal  meningitis
nd  started  amphotericin  B  and  ﬂucytosine.  To  evaluate  the
xtension  of  KS,  an  upper  endoscopy  was  performed  and
evealed  two  reddish,  round  and  elevated  lesions  in  the
ody  of  stomach  (Fig.  1),  suggestive  of  KS  lesions.  The  his-
ological  exam  showed  a  spindle-cell  proliferation  in  the
ubmucosa  (Fig.  2),  highlighted  with  immunochemistry  for
D31  and  multiple  cells  positive  for  human  herpesvirus  8
HHV8),  conﬁrming  the  diagnosis  (Fig.  3).  The  skin  lesions
ize  decreased  with  HAART,  precluding  the  necessity  of  sys-
emic  chemotherapy.  After  nearly  one  month  of  intense
herapy  for  infectious  complications,  the  patient  status
mproved  and  he  was  discharged.
KS  is  a  vascular  tumor  associated  with  HHV8  infection
nd,  while  rare  in  immunocompetent  host,  it  is  the  most
ommon  neoplasm  among  HIV-infected  patients.1--3
Visceral  disease  is  uncommon  and,  most  commonly,  the
ung  and  gastrointestinal  (GI)  tract  are  involved.2,3
Most  patients  with  GI  involvement  are  asymptomatic,  but
ay  present  with  non-speciﬁc  symptoms  such  as  weight  loss,
iarrhea  and  abdominal  pain.4 In  some  cases,  it  may  lead  to
 by Elsevier Espan˜a, S.L.U. This is an open access article under the
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Figure  1  (a  and  b)  Endoscopic  ﬁndings,  revealing  two  reddish,  round  and  elevated  lesions  in  the  greater  curvature  of  proximal
body (a)  and  in  the  lesser  curvature  of  distal  body  (b).
Figure  2  Hematoxylin  and  eosin  stain  showing  spindle  cell
Figure  3  Immunohistochemical  stain  for  human  herpes  virus
8 showing  a  diffusely  positive  latent  nuclear  antigen  staining
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proper  KS  staging  and  selection  of  the  appropriate  ther-proliferation  in  the  submucosa.
hemorrhage,  abdominal  pain,  gastric  outlet  obstruction  or
intussusception.1 GI-KS  is  endoscopically  evident  by  appear-
ance  which  ranges  from  a  red  maculopapular  lesion  to  a
darker,  nodular  or  polypoid  lesion.5 In  more  severe  disease,
patients  may  present  with  a  volcanolike  mass  with  a  central
umbilication  or  ulceration  which  can  bleed  on  contact.5
The  diagnosis  is  usually  based  on  the  character-
istic  appearance  of  cutaneous  or  mucosal  lesions,
and  conﬁrmatory  testing  with  histopathology  and
immunohistochemistry.2,5 On  histopathology,  KS  is  charac-
terized  as  spindle  cell  proliferation  that  forms  irregular
vascular  channels  in  the  submucosal  layer.5 To  make  a
diagnosis  of  KS,  the  presence  of  HHV8  is  necessary  and
immunohistochemical  testing  is  recommended  for  all
specimens  with  spindle  cell  morphology.2,5KS  usually  responds  to  HAART,  nevertheless,  administra-
tion  of  systemic  cytotoxic  chemotherapy  is  warranted  in
a
pf the  spindle  cells,  conﬁrming  the  diagnosis  of  diffuse  visceral
aposi’s  sarcoma.
atients  with  advanced,  symptomatic  or  rapidly  progressive
isease.2,4
Endoscopic  evaluation  is  required  in  AIDS  patients  that
resent  with  GI  symptoms.2 However,  in  patients  that  are
symptomatic,  the  beneﬁt  of  endoscopy  remain  a  topic  of
ebate.  Nevertheless,  early  endoscopic  evaluation  allows  apeutic  options,  preventing  complications  associated  with
rogression  of  the  disease.
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